OCT Eccentric Fixation and Amblyopia in Children

Description

The objectives of this proposal are to characterize the relationship between OCT eccentric fixation (OCT-EF), fixation eye movement (FEM), macular sensitivity in children with amblyopia.

Conditions

Amblyopia

Talk to us

Study Overview

On this page

Study Details

Study overview

The objectives of this proposal are to characterize the relationship between OCT eccentric fixation (OCT-EF), fixation eye movement (FEM), macular sensitivity in children with amblyopia.

OCT Eccentric Fixation, Fixation Stability, and Amblyopia in Children

OCT Eccentric Fixation and Amblyopia in Children

Condition
Amblyopia
Intervention / Treatment

-

Contacts and Locations

New York

SUNY College of Optometry, New York, New York, United States, 10036

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. children with best-corrected visual acuity (BCVA) of 20/40 (equivalent to 0.3 logMAR) or worse in the amblyopic eye (ranging from 20/40 to 20/400), and interocular difference of BCVA was at least two logMAR lines,
  • 2. ocular causes of amblyopia that were identified as refractive(i.e., anisometropic, strabismus, or strabismic-anisometropic.
  • * Anisometropia included interocular difference of spherical equivalent \>=1D or interocular difference of astigmatism cylinder magnitude \>=1D;
  • * strabismus included those with deviation \>=10PD or good alignment after prior strabismus surgery;
  • * combined type included those who meet the criteria of both anisometropia and strabismus.
  • * For the patching group, we will enroll 15 children with strabismic amblyopia who are prescribed patching treatment. Age: 4-12 years old.
  • * For the foveation therapy group, we will enroll 15 children with strabismic amblyopia who are prescribed foveation therapies. Age: 8-16 years old.
  • * born before 32 weeks gestational age;
  • * neurologic, developmental, or systemic illnesses known to be associated with ocular pathologies;
  • * congenital or acquired macular pathology.

Ages Eligible for Study

4 Years to 16 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

State University of New York College of Optometry,

Jingyun Wang, PRINCIPAL_INVESTIGATOR, SUNY College of Optmetry

Study Record Dates

2026-01-24